Repurposing doxorubicin and digoxin as novel treatment options for Pulmonary Arterial Hypertension (PAH)
Doxorubicin, Digoxin, ERK1, ABL1, IGF1R, Bone morphogenic protein (BMP), Transforming growth factor (TGFβ), Pulmonary arterial hypertension (PAH)
Networked Digital Library of Theses and Dissertations